rs772429581
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP5
The NM_020041.3(SLC2A9):c.354_355insC(p.Ile119HisfsTer27) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000223 in 1,614,092 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000022 ( 0 hom. )
Consequence
SLC2A9
NM_020041.3 frameshift
NM_020041.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.747
Genes affected
SLC2A9 (HGNC:13446): (solute carrier family 2 member 9) This gene encodes a member of the SLC2A facilitative glucose transporter family. Members of this family play a significant role in maintaining glucose homeostasis. The encoded protein may play a role in the development and survival of chondrocytes in cartilage matrices. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PP5
Variant 4-9996836-T-TG is Pathogenic according to our data. Variant chr4-9996836-T-TG is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 350238.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=1, Uncertain_significance=1, Pathogenic=2}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC2A9 | NM_020041.3 | c.354_355insC | p.Ile119HisfsTer27 | frameshift_variant | 3/12 | ENST00000264784.8 | NP_064425.2 | |
SLC2A9-AS1 | NR_183861.1 | n.308-2255dup | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC2A9 | ENST00000264784.8 | c.354_355insC | p.Ile119HisfsTer27 | frameshift_variant | 3/12 | 1 | NM_020041.3 | ENSP00000264784 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152228Hom.: 0 Cov.: 34
GnomAD3 genomes
AF:
AC:
4
AN:
152228
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251362Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135856
GnomAD3 exomes
AF:
AC:
6
AN:
251362
Hom.:
AF XY:
AC XY:
4
AN XY:
135856
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461864Hom.: 0 Cov.: 57 AF XY: 0.0000289 AC XY: 21AN XY: 727240
GnomAD4 exome
AF:
AC:
32
AN:
1461864
Hom.:
Cov.:
57
AF XY:
AC XY:
21
AN XY:
727240
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152228Hom.: 0 Cov.: 34 AF XY: 0.00 AC XY: 0AN XY: 74382
GnomAD4 genome
AF:
AC:
4
AN:
152228
Hom.:
Cov.:
34
AF XY:
AC XY:
0
AN XY:
74382
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:5Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hypouricemia, renal, 2 Pathogenic:3Uncertain:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 22, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The SLC2A9 c.354dupC (p.Ile119HisfsTer27) variant results in a frameshift, and is predicted to result in premature termination of the protein. The p.Ile119HisfsTer27 variant has been reported in a homozygous state in two siblings with renal hypouricemia (Stiburkova et al. 2011). The variant was absent from 150 controls but is reported at a frequency of 0.00005 in the European (non-Finnish) population of the Exome Aggregation Consortium. Functional studies in Xenopus oocytes demonstrated that the p.Ile119HisfsTer27 variant resulted in a significant decrease in urate uptake compared to wildtype (Mancikova et al. 2015). Due to the potential impact of frameshift variants and the supporting evidence from the literature, the p.Ile119HisfsTer27 variant is classified as a variant of unknown significance but suspicious for pathogenicity for renal hypouricemia. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Pathogenic, no assertion criteria provided | clinical testing | Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare | Nov 05, 2019 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jun 30, 2021 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 10, 2023 | This sequence change creates a premature translational stop signal (p.Ile119Hisfs*27) in the SLC2A9 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC2A9 are known to be pathogenic (PMID: 19926891, 21256783, 21536615, 24628802). This variant is present in population databases (rs772429581, gnomAD 0.005%). This premature translational stop signal has been observed in individual(s) with clinical features of renal hypouricemia (PMID: 21256783). This variant is also known as p.I118HfsX27. ClinVar contains an entry for this variant (Variation ID: 350238). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | SLC2A9: PM2, PM3, PVS1:Moderate, PS3:Supporting - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at